来自临床甲状腺学编辑的问候

{"title":"来自临床甲状腺学编辑的问候","authors":"","doi":"10.1089/ct.2023;35.345-346","DOIUrl":null,"url":null,"abstract":"Clinical Thyroidology®Vol. 35, No. 9 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.345-346AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Greetings to our readers. This month's issue of Clinical Thyroidology includes several special highlights that are not to be missed. First, we begin with the next fireside chat in the American Thyroid Association's continuing series celebrating our centennial anniversary. In this discussion, Drs. Victor Bernet and Anne Cappola reflect on their thoughts and perspectives on the topic of thyroid hormone use and abuse, framed in the history of the development of thyroid hormone replacement. Then, as part of our ongoing collaboration with the International Thyroid Oncology Group (ITOG), in an editorial Drs. Laura Boucai, Ashish Chintakuntlawar, and David Shonka, Jr., give a brief summary of the ITOG community and its past and current work in coordinating the group's available clinical trials of various advanced thyroid cancers. I hope that this excellent summary is helpful to clinicians worldwide who are managing the care of patients with metastatic or advanced disease.Moving on to the topic of pediatric thyroid disease, Dr. Gary Francis reviews a study on serum thyroid function tests in children with Down syndrome. Drs. Maryam Makowski and Elizabeth McAninch then provide their perspective on a study examining low T3 syndrome in malnourished hospitalized patients, while Dr. Anupam Kotwal reviews a study reporting a real-world experience with teprotumumab and tocilizumab use in patients with moderate-to-severe steroid-resistant thyroid eye disease.On the topic of thyroid nodules and thyroid cancer, Drs. Kristen HoSang and Lindsay Kuo review a study assessing the role of age in patients who undergo active surveillance of small, sonographically low-risk thyroid nodules. Meanwhile, Drs. Jessica Bindra, Matti Gild, and Venessa Tsang examine a study reporting the benefit of preoperative molecular testing of cytologically high-risk thyroid nodules, while Drs. Paul Stewardson and Mayumi Endo review how the allelic frequency of BRAF V600E and TERT promoter mutations in thyroid nodules may be a useful predictor of malignancy. The potential benefit of microwave ablation for the treatment of select micropapillary thyroid cancers is reviewed by Dr. Jie Liu. Dr. Sara Ahmadi discusses a recent study on the comparison of diffuse sclerosing, classic, and tall-cell variant papillary thyroid cancers. Finally, Drs. Ricardo Villela and Ricardo Correa summarize a recent study examining the adverse effects of radioactive iodine ablation on the lacrimal and salivary glands.I invite everyone to visit our various social media channels, where we recap the featured highlights from each month's issue and discuss other topics related to the latest clinical thyroid literature. All are welcome to join us at:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgMy thanks again to the editorial board of Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), as led by Dr. Alan Farwell, for their work in providing short summaries of our Clinical Thyroidology articles each month. These freely available, quicker reads are helpful to patients and to the general public who are interested in learning more about recently published studies in the clinical thyroid literature.We will continue to provide reviews, commentaries, editorials, and perspectives on the most relevant clinical thyroid studies from the published literature. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at [email protected].Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology®.Sep 2023.345-346.http://doi.org/10.1089/ct.2023;35.345-346Published in Volume: 35 Issue 9: September 13, 2023PDF download","PeriodicalId":72629,"journal":{"name":"Clinical thyroidology","volume":"26 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Greetings From the Editor of <i>Clinical Thyroidology</i>\",\"authors\":\"\",\"doi\":\"10.1089/ct.2023;35.345-346\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Clinical Thyroidology®Vol. 35, No. 9 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.345-346AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Greetings to our readers. This month's issue of Clinical Thyroidology includes several special highlights that are not to be missed. First, we begin with the next fireside chat in the American Thyroid Association's continuing series celebrating our centennial anniversary. In this discussion, Drs. Victor Bernet and Anne Cappola reflect on their thoughts and perspectives on the topic of thyroid hormone use and abuse, framed in the history of the development of thyroid hormone replacement. Then, as part of our ongoing collaboration with the International Thyroid Oncology Group (ITOG), in an editorial Drs. Laura Boucai, Ashish Chintakuntlawar, and David Shonka, Jr., give a brief summary of the ITOG community and its past and current work in coordinating the group's available clinical trials of various advanced thyroid cancers. I hope that this excellent summary is helpful to clinicians worldwide who are managing the care of patients with metastatic or advanced disease.Moving on to the topic of pediatric thyroid disease, Dr. Gary Francis reviews a study on serum thyroid function tests in children with Down syndrome. Drs. Maryam Makowski and Elizabeth McAninch then provide their perspective on a study examining low T3 syndrome in malnourished hospitalized patients, while Dr. Anupam Kotwal reviews a study reporting a real-world experience with teprotumumab and tocilizumab use in patients with moderate-to-severe steroid-resistant thyroid eye disease.On the topic of thyroid nodules and thyroid cancer, Drs. Kristen HoSang and Lindsay Kuo review a study assessing the role of age in patients who undergo active surveillance of small, sonographically low-risk thyroid nodules. Meanwhile, Drs. Jessica Bindra, Matti Gild, and Venessa Tsang examine a study reporting the benefit of preoperative molecular testing of cytologically high-risk thyroid nodules, while Drs. Paul Stewardson and Mayumi Endo review how the allelic frequency of BRAF V600E and TERT promoter mutations in thyroid nodules may be a useful predictor of malignancy. The potential benefit of microwave ablation for the treatment of select micropapillary thyroid cancers is reviewed by Dr. Jie Liu. Dr. Sara Ahmadi discusses a recent study on the comparison of diffuse sclerosing, classic, and tall-cell variant papillary thyroid cancers. Finally, Drs. Ricardo Villela and Ricardo Correa summarize a recent study examining the adverse effects of radioactive iodine ablation on the lacrimal and salivary glands.I invite everyone to visit our various social media channels, where we recap the featured highlights from each month's issue and discuss other topics related to the latest clinical thyroid literature. All are welcome to join us at:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgMy thanks again to the editorial board of Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), as led by Dr. Alan Farwell, for their work in providing short summaries of our Clinical Thyroidology articles each month. These freely available, quicker reads are helpful to patients and to the general public who are interested in learning more about recently published studies in the clinical thyroid literature.We will continue to provide reviews, commentaries, editorials, and perspectives on the most relevant clinical thyroid studies from the published literature. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at [email protected].Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology®.Sep 2023.345-346.http://doi.org/10.1089/ct.2023;35.345-346Published in Volume: 35 Issue 9: September 13, 2023PDF download\",\"PeriodicalId\":72629,\"journal\":{\"name\":\"Clinical thyroidology\",\"volume\":\"26 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical thyroidology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/ct.2023;35.345-346\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical thyroidology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ct.2023;35.345-346","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

临床Thyroidology®卷。35、第9号编辑的问候免费访问临床甲状腺病学编辑的问候在线发布:2023年9月13日https://doi.org/10.1089/ct.2023;35.345-346AboutSectionsPDF/EPUB权限和引用次数下载CitationsTrack引用次数添加到收藏回到出版物分享分享在facebook上推特链接在redditemail问候我们的读者。本月的《临床甲状腺学》包括几个不容错过的特别亮点。首先,我们从美国甲状腺协会庆祝百年纪念系列节目的下一个炉边谈话开始。在这次讨论中,dr。Victor Bernet和Anne Cappola在甲状腺激素替代疗法发展的历史框架下,反思了他们对甲状腺激素使用和滥用的想法和观点。然后,作为我们与国际甲状腺肿瘤组织(ITOG)持续合作的一部分,在一篇社论中,dr。Laura Boucai, Ashish Chintakuntlawar和David Shonka, Jr.简要总结了ITOG社区及其过去和现在在协调各种晚期甲状腺癌临床试验方面的工作。我希望这篇优秀的总结对全世界的临床医生有帮助,他们正在管理转移性或晚期疾病患者的护理。继续讨论儿童甲状腺疾病的话题,Gary Francis博士回顾了唐氏综合症儿童血清甲状腺功能测试的研究。Drs。Maryam Makowski和Elizabeth mccaninch随后就一项研究提供了他们对营养不良住院患者低T3综合征的看法,而Anupam Kotwal博士则回顾了一项研究,该研究报告了teprotumumab和tocilizumab在中度至重度类固醇抵抗性甲状腺眼病患者中的实际使用经验。在甲状腺结节和甲状腺癌的话题上,Kristen HoSang和Lindsay Kuo回顾了一项研究,该研究评估了年龄在接受小的、超声低风险甲状腺结节积极监测的患者中的作用。与此同时,Drs。Jessica Bindra, Matti Gild和Venessa Tsang研究了一项报告术前分子检测细胞学上高风险甲状腺结节的益处的研究。Paul Stewardson和Mayumi Endo回顾了甲状腺结节中BRAF V600E和TERT启动子突变的等位基因频率如何可能是恶性肿瘤的有用预测因子。刘杰医生综述了微波消融治疗甲状腺微乳头状癌的潜在益处。Sara Ahmadi博士讨论了最近对弥漫性硬化、典型和高细胞变异型甲状腺乳头状癌的比较研究。最后,Drs。里卡多·维拉和里卡多·科雷亚总结了最近的一项研究,研究了放射性碘消融对泪腺和唾液腺的不良影响。我邀请大家访问我们的各种社交媒体渠道,在那里我们回顾每个月问题的特色亮点,并讨论与最新临床甲状腺文献相关的其他主题。欢迎所有人加入我们的行列:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgMy再次感谢公众临床甲状腺学编辑委员会(CTFP) (https://www.thyroid.org/patient-thyroid-information/ct-for-patients),由Alan Farwell博士领导。感谢他们每月为我们的临床甲状腺学文章提供简短的摘要。这些免费的,快速的阅读是有帮助的病人和一般公众谁有兴趣了解更多关于最近发表的临床研究甲状腺文献。我们将继续从已发表的文献中提供最相关的甲状腺临床研究的综述、评论、社论和观点。如果您对临床甲状腺学感兴趣,您可以在https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank上再次找到向编辑提交信件和选择客座社论的指南,这些社论涵盖了临床甲状腺疾病管理的及时和创新方面。如果有任何问题或意见,请发邮件至[email protected]。最热烈的问候,Angela M. Leung,医学博士,医学硕士,《临床甲状腺学》主编,figureresreferencesrelateddetails第35卷第9期2023年9月信息©版权所有2023,Mary Ann Liebert, inc .引用本文:《临床甲状腺学》编辑的问候。临床Thyroidology®。Sep 2023.345-346.http://doi.org/10.1089/ct.2023;35.345-346Published Volume: 35 Issue 9: September 13, 2023PDF下载
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Greetings From the Editor of Clinical Thyroidology
Clinical Thyroidology®Vol. 35, No. 9 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyPublished Online:13 Sep 2023https://doi.org/10.1089/ct.2023;35.345-346AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Greetings to our readers. This month's issue of Clinical Thyroidology includes several special highlights that are not to be missed. First, we begin with the next fireside chat in the American Thyroid Association's continuing series celebrating our centennial anniversary. In this discussion, Drs. Victor Bernet and Anne Cappola reflect on their thoughts and perspectives on the topic of thyroid hormone use and abuse, framed in the history of the development of thyroid hormone replacement. Then, as part of our ongoing collaboration with the International Thyroid Oncology Group (ITOG), in an editorial Drs. Laura Boucai, Ashish Chintakuntlawar, and David Shonka, Jr., give a brief summary of the ITOG community and its past and current work in coordinating the group's available clinical trials of various advanced thyroid cancers. I hope that this excellent summary is helpful to clinicians worldwide who are managing the care of patients with metastatic or advanced disease.Moving on to the topic of pediatric thyroid disease, Dr. Gary Francis reviews a study on serum thyroid function tests in children with Down syndrome. Drs. Maryam Makowski and Elizabeth McAninch then provide their perspective on a study examining low T3 syndrome in malnourished hospitalized patients, while Dr. Anupam Kotwal reviews a study reporting a real-world experience with teprotumumab and tocilizumab use in patients with moderate-to-severe steroid-resistant thyroid eye disease.On the topic of thyroid nodules and thyroid cancer, Drs. Kristen HoSang and Lindsay Kuo review a study assessing the role of age in patients who undergo active surveillance of small, sonographically low-risk thyroid nodules. Meanwhile, Drs. Jessica Bindra, Matti Gild, and Venessa Tsang examine a study reporting the benefit of preoperative molecular testing of cytologically high-risk thyroid nodules, while Drs. Paul Stewardson and Mayumi Endo review how the allelic frequency of BRAF V600E and TERT promoter mutations in thyroid nodules may be a useful predictor of malignancy. The potential benefit of microwave ablation for the treatment of select micropapillary thyroid cancers is reviewed by Dr. Jie Liu. Dr. Sara Ahmadi discusses a recent study on the comparison of diffuse sclerosing, classic, and tall-cell variant papillary thyroid cancers. Finally, Drs. Ricardo Villela and Ricardo Correa summarize a recent study examining the adverse effects of radioactive iodine ablation on the lacrimal and salivary glands.I invite everyone to visit our various social media channels, where we recap the featured highlights from each month's issue and discuss other topics related to the latest clinical thyroid literature. All are welcome to join us at:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgMy thanks again to the editorial board of Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), as led by Dr. Alan Farwell, for their work in providing short summaries of our Clinical Thyroidology articles each month. These freely available, quicker reads are helpful to patients and to the general public who are interested in learning more about recently published studies in the clinical thyroid literature.We will continue to provide reviews, commentaries, editorials, and perspectives on the most relevant clinical thyroid studies from the published literature. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at [email protected].Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 35Issue 9Sep 2023 Information© Copyright 2023, Mary Ann Liebert, Inc.To cite this article:Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology®.Sep 2023.345-346.http://doi.org/10.1089/ct.2023;35.345-346Published in Volume: 35 Issue 9: September 13, 2023PDF download
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信